Mueller S, Ziemssen T, Diehm C, Duncker T, Hoffmanns P, Thate-Waschke I, Schürks M, Wilke T. How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians' Preferences. Patient Prefer Adherence. 2020 Feb 14;14:267-276.

Wilke T, Groth A, Long G, Tatro A, Sun D. Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany. Clin Ther. 2020 Jan;42(1):130-143.e3.

Mevius A, Wilke T, Fuchs A, Kloppenburg A, Engel S, Linder R, Breithardt G. Catheter Ablation Versus Antiarrhythmic Medication in Patients with Atrial Fibrillation: a Propensity-Matched Analysis Based on a German Claims Data Set.  J Cardio Vasc Med 2019, 5: 1-12

Brandes A, Groth A, Gottschalk F, Wilke T, Ratsch BA, Orzechowski HD, Fuchs A, Deiters B, Bokemeyer B. Real-world biologic treatment and associated cost in patients with inflammatory bowel disease. Z Gastroenterol. 2019 Jul;57(7):843-851

Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M. Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage. Diabetes Metab Syndr Obes. 2019 Jul 24;12:1225-1237

Wilke T, Mueller S, Bauer S, Pitura S, Probst L, Ratsch BA, Salwender H.  Treatment of relapsed refractory multiple myeloma: which new PI-based combination treatments do patients prefer? Patient Prefer Adherence. 2018 Nov 9;12:2387-2396

Mueller S, Gottschalk F, Groth A, Meeraus W, Driessen M, Kohlmann T, Wilke T.  Primary data, claims data, and linked data in observational research: the case of COPD in Germany . Respiratory Research (2018) 19:161

Wilke T, Mueller S, Bloempott S, Rimle M, Amann-Vesti B, Schaefer S.  Präferenzen von Patienten mit Vorhofflimmern bezüglich der Therapieeigenschaften von oralen Antikoagulanzien: Ein Discrete-Choice-Experiment in der Schweiz. ARS MEDICI (2018) 13:605-606

Mueller S, Groth A, Spitzer SG, Schramm A, Pfaff A, Maywald U. Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset. Pragmat Obs Res. 2018 May 1;9:1-10

Wilke T, Groth A, Fuchs A, Pfannkuche M, Maywald U. Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients. Eur J Clin Pharmacol. 2017 Nov;73(11):1437-1447